Evoke Pharma (NASDAQ:EVOK) Shares Cross Below 200 Day Moving Average – What’s Next?

Evoke Pharma, Inc. (NASDAQ:EVOK)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.59 and traded as low as $5.14. Evoke Pharma shares last traded at $5.53, with a volume of 15,621 shares.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on Evoke Pharma in a research report on Saturday. They set a “sell” rating on the stock.

Evoke Pharma Trading Up 3.3 %

The stock has a market capitalization of $47.37 million, a PE ratio of -3.01 and a beta of 0.39. The stock’s fifty day simple moving average is $4.81 and its 200-day simple moving average is $5.57.

Evoke Pharma (NASDAQ:EVOK) last released its quarterly earnings results on Tuesday, August 13th. The specialty pharmaceutical company reported ($0.93) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.72) by ($0.21). Evoke Pharma had a negative net margin of 86.74% and a negative return on equity of 964.25%. The firm had revenue of $2.55 million for the quarter.

About Evoke Pharma

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.